samedan logo
 
 
spacer
home > pmps > summer 2021 > future-proofing pharma manufacturing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Future-Proofing Pharma Manufacturing

There is no doubt that living through a global pandemic will change the way people regard work-based hygiene and contagious illnesses well beyond COVID-19-related restrictions. People have become more aware of best hygiene practices, and the risk of colds, flu, and stomach bugs causing absenteeism among the workforce.

On top of this, the pandemic has proved how effective being mindful of good hygiene is when it comes to keeping people well, as the UK sickness absence rate fell by 1.8% to its lowest ever recorded level in 2020, despite COVID-19 (1). The Office for National Statistics (ONS) has cited minor illnesses such as coughs and colds as the number one reason for sick leave every year since records began in 1995, accounting for 27% of sick days in 2018 and 26% in 2020.

This demonstrates a clear business advantage for pharmaceutical manufacturers to permanently implement more stringent hygiene procedures. Improving workplace cleanliness will prevent illness from spreading through workforces and, in turn, minimise sick absence and boost productivity.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
In response to the coronavirus pandemic, Jarek Sarek, Head of Engineering and Technical Operations at Uvisan, led the virtual reality (VR) experience business, Immotion Group, in finding an efficient solution for keeping VR headsets sanitised without using wipes or chemicals which would damage them. Prior to working with Immotion, Jarek had 15-years’ experience working in the food and drinks industry and applied the UV-C technology used to kill pathogens in food to disinfect VR headsets, resulting in Uvisan. Jarek has an undergraduate qualification in Electronic Digital and Analogue Systems, a Master’s degree in Mechanical Engineering, and has led the development and rigorous testing of Uvisan cabinets and Cleanroom by Uvisan.
spacer
Jarek Sarek
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sanofi invests $180 million equity in Owkin’s artificial intelligence and federated learning to advance oncology pipeline

Sanofi announced today an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development programmes in four exclusive types of cancer, with a total payment of $90 million for three years plus additional research milestone-based payments.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement